512600 — Astal Laboratories Balance Sheet
0.000.00%
Last trade - 00:00- IN₹976.73m
- IN₹1.05bn
- IN₹642.31m
- 26
- 70
- 67
- 57
Annual balance sheet for Astal Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.313 | 0.183 | 0.844 | 60.8 | 17.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 51.5 | 51.3 | 31.7 | 158 | 277 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 51.8 | 51.5 | 61.1 | 267 | 456 |
| Net Property, Plant And Equipment | 0.531 | 0.135 | 0.056 | 6.9 | 114 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 53.1 | 52.3 | 99.1 | 366 | 633 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.3 | 0.678 | 47.3 | 130 | 268 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.32 | 0.689 | 47.3 | 133 | 273 |
| Common Stock | |||||
| Other Equity | |||||
| Total Equity | 51.8 | 51.6 | 51.8 | 233 | 360 |
| Total Liabilities & Shareholders' Equity | 53.1 | 52.3 | 99.1 | 366 | 633 |
| Total Common Shares Outstanding |